Among 4 hit compounds, LY-294,002 and oxytetracycline remarkably exhibited more sensitive effect in CD133+ HCC than CD133− HCC significantly at high concentrations [Fig. 3A]. The gene discussed is PROM1; the disease is hepatocellular carcinoma.